Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations

Drug Development and Industrial Pharmacy

Volumn 32, Issue 2, 2006, Pages 243-251

  El Sabawi, Dinna ^a   Price, Robert ^a   Edge, Stephen ^a   Young, Paul M ^b  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dry powder inhaler; Lactose; Surface dissolved

Indexed keywords

DRUG CARRIER; EXCIPIENT; LACTOCHEM; LACTOSE; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; CONTROLLED DRUG RELEASE; CRYSTAL STRUCTURE; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; DRY POWDER; HIGH TEMPERATURE; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER INHALER; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TEMPERATURE DEPENDENCE;

ADRENERGIC BETA-AGONISTS; AEROSOLS; ALBUTEROL; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EXCIPIENTS; HEATING; LACTOSE; MICROSCOPY, ELECTRON, SCANNING; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; POWDERS; SOLUBILITY; SURFACE PROPERTIES; X-RAY DIFFRACTION;

EID: 33644998664     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500466395     Document Type: Article

References (28)

1. Carr, R. L., Jr. (1965). Evaluating flow properties of solids. Chem. Eng., 163-168.
2. Ferrari, F., Cocconi, D., Bettini, R., Giordano, F., Santi, P., Tobyn, M., Price, R., Young, P. M., Caramella, C., & Colombo, P. (2004). The surface roughness of lactose particles can be modulated by wet-smoothing using a high shear mixer. AAPS PharmSciTech., 5, Article 60 (http://www. aapspharmscitech.org).
3. Flament, M. P., Leterme, P., & Gayot, A. (2004). The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. International Journal of Pharmaceutics, 275(1-2), 201-209.
4. Ganderton, D., & Kassem, N. M. (1992). Advances in pharmaceutical sciences. London: Academic Press.
5. Hallworth, G. W., & Westmoreland, D. G. (1987). The twin impinger: a simple device for assessing the delivery of drugs from metered dose pressurized aerosol inhalers. Journal of Pharmacy and Pharmacology, 39, 966-972.
6. Heng, P. W., Chan, L. W., & Lim, L. T. (2000). Quantification of the surface morphologies of lactose carriers and the effect on the in vitro deposition of salbutamol supphate. Chemical and Pharmaceutical Bulletin, 48(3), 393-398.
7. Iida, K., Hayakawa, Y., Okamoto, H., Danjo, K., & Leuenberger, H. (2003). Reparation of dry powder inhalation by surface treatment of lactose. Chemical and Pharmaceutical Bulletin, 53(1), 1-5.
8. Islam, N., Stewart, P., Larson, I., & Hartley, P. (2004). Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures? Pharmaceutical Research, 21(3), 492-499.
9. Kawashima, Y., Serigano, T., Hino, T., Yamamoto, H., & Takeuchi, H. (1998). Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. International Journal of Pharmaceutics, 172(1-2), 179-188.
10. Kibbe, A. H., & Weller, P. J. (2003). Lactose. In Handbook of Pharmaceutical Excipients, (4th Ed.), Rowe, R. C., Sheskey, P. J., Weller, P. J., Eds.; London: Pharmaceutical Ress, 323-332.
11. Larhrib, H., Zeng, X. M., Martin, G. P., Marriott, C., & Ritchard, J. (1999). The use of different grades of lactose as a carrier for aerosolized salbutamol sulphate. International Journal of Pharmaceutics, 191(1), 1-14.
12. Larhrib, H., Martin, G.P., Marriott, C., & Prime, D. (2003a). The influence of carrier and drug morphology on drug delivery from dry powder formulations. International Journal of Pharmaceutics, 257(1-2), 283-296.
13. Larhrib, H., Martin, G. P., Prime, D., & Marriott, C. (2003b). Characterization and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolized salbutamol sulfate from dry powder inhalers. European Journal of Pharmaceutical Science, 19(4), 211-221.
14. Louey, M. D., Razia, S., & Stewart, P. J. (2003). Influence of physicochemical carrier properties on the in vitro aerosol deposition from interactive mixtures. International Journal of Pharmaceutics, 252(1-2), 87-98.
15. Lucas, P., Anderson, K., & Staniforth, J. N. (1998). Protein deposition from dry powder inhalers: fine partide multiplets as performance modifiers. Pharmaceutical Research, 15(4), 562-569.
16. Lucas, P., Anderson, K., Potter, U. J., & Staniforth, J. N. (1999). Enhancement of small size dry powder aerosol formulations using ultra low density additive. Pharmaceutical Research, 16(10), 1643-1647.
17. Rajah, K. K., & Benford, D. E. (1998). The ALM guide to lactose properties and uses. The Hague: The Association of Lactose Manufacturers.
18. Schiavone, H., Palakodaty, S., Clark, A., York, P., & Tzannis, S.T. (2004). Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhaers. International Journal of Pharmaceutics, 281(1-2), 55-66.
19. Smith, I. J., & Parry-Billings, M. (2003). The inhalers of the future? A review of dry powder devices on the market today. Pulmonary Pharmacology and Theraputics, 16(2), 79-95.
20. Staniforth, J. N. (1997). Improvement in dry powder inhaler performance: surface passivation effects. Proceeding of Drug Delivery to the Lungs (London), VIII, 85-86.
21. Steckel, H., & Müller, B. W. (1997). In vitro evaluation of dry powder inhalers II: Influence of carrier particle size and concentration on in vitro deposition. International Journal of Pharmaceutics, 154(1), 31-37.
22. Steckel, H., Markefkaa, P., teWierik, H., & Kammelar, R. (2004). Functionality testing of inhalation grade lactose. European Journal of Pharmaceutics and Biopharmaceutics, 57(3), 495-505.
23. Young, P. M., Cocconi, D., Colombo, P., Bettini, R., Price, R., Steele, D. F., & Tobyn, M. J. (2002). Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". Journal of Pharmacy and Pharmacology, 54(10), 1339-1344.
24. Young, P. M., & Rice, R. (2004). The influence of humidity on the aerosolization of micronized and SEDS produced salbutamol sulphate. European of Journal of Pharmaceutical Science, 22(4), 235-240.
25. Zeng, X. M., Martin, G. P., Marriott, C., & Pritchard, J. (2000). The influence of carrier morphology on drug delivery by dry powder inhalers. International Journal of Pharmaceutics, 200(1), 93-106.
26. Zeng, X. M., Martin, G. P., Tee, S. K., & Marriott, C. (1998). The role of fine partide lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream. International Journal of Pharmaceutics, 176(1), 99-110.
27. Zeng, X. M., Martin, G. P., Marriott, C., & Ritchard, J. (2001). The use of lactose recrystallized from Carbopol gels as a carrier for aerosolized salbutamol sulphate. European of Journal of Pharmaceutical Sciences, 51(1), 55-62.
28. Zeng, X. M., Martin, G. P., Tee, S-K., Ghoush, A. B., & Marriott, C. (1999). Effects of partide size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation. Internationa Journal of Pharmaceutics, 182(2), 133-144.